Crossmark

Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma

Crossref DOI link: https://doi.org/10.1007/s12672-022-00582-2

Published Online: 2022-11-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ronchetti, Domenica

Favasuli, Vanessa Katia

Silvestris, Ilaria

Todoerti, Katia

Torricelli, Federica

Bolli, Niccolò

Ciarrocchi, Alessia

Taiana, Elisa

Neri, Antonino
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (IG25739, IG24365)

Horizon 2020 Framework Programme (no. 817997)
License Information

Text and Data Mining valid from 2022-11-11

Version of Record valid from 2022-11-11
More Information

Article History

Received: 16 July 2022

Accepted: 25 October 2022

First Online: 11 November 2022

Declarations

:

: Written informed consent was obtained from all patients included in the proprietary, publicly available dataset (GSE116294) in accordance with the declaration of Helsinki. The study was approved by the Ethical Committee of the University of Milan (N°24/15, May 06 2015).

: Not applicable.

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below